aluates Reports

$ 0.0

Automative

Global Opiate Antagonist Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-33A13085

Global Opiate Antagonist Market Research Report 2023

BUY CHAPTERS

Global Opiate Antagonist Market Research Report 2024

Code: QYRE-Auto-33A13085

Report

August 2024

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Sun Pharmaceutical Industries

Teva Pharmaceuticals

Cardinal Health

Dr. Reddy’s Laboratories

Mylan Institutional

Perrigo Pharmaceuticals

AuroMedics Pharma

Akorn

Alkermes plc

Baxter Pharmaceutical

Adapt Pharmaceuticals

GIV Repack

Intl Medication Systems

Kaleo Pharma

Somerset Pharma

Opiate Antagonist Market

The global Opiate Antagonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Opiate Antagonist is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Opiate Antagonist is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Opiate Antagonist in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Opiate Antagonist include Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health, Baxter Pharmaceutical, Adapt Pharmaceuticals, Dr. Reddy's Laboratories, GIV Repack and Intl Medication Systems, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Opiate Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opiate Antagonist.

Report Scope

The Opiate Antagonist market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opiate Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opiate Antagonist companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Opiate Antagonist Market Report

Report Metric	Details
Report Name	Opiate Antagonist Market
Segment by Type	0.4 mg/ml 1 mg/ml 2 mg/ml
Segment by Application	Hospital Clinics Pharmacy Home Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health, Baxter Pharmaceutical, Adapt Pharmaceuticals, Dr. Reddy's Laboratories, GIV Repack, Intl Medication Systems, Kaleo Pharma, Mylan Institutional, Perrigo Pharmaceuticals, AuroMedics Pharma, Somerset Pharma, Akorn, Alkermes
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opiate Antagonist companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Opiate Antagonist Market report?

Ans: The main players in the Opiate Antagonist Market are Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health, Baxter Pharmaceutical, Adapt Pharmaceuticals, Dr. Reddy's Laboratories, GIV Repack, Intl Medication Systems, Kaleo Pharma, Mylan Institutional, Perrigo Pharmaceuticals, AuroMedics Pharma, Somerset Pharma, Akorn, Alkermes

What are the Application segmentation covered in the Opiate Antagonist Market report?

Ans: The Applications covered in the Opiate Antagonist Market report are Hospital, Clinics, Pharmacy, Home, Others

What are the Type segmentation covered in the Opiate Antagonist Market report?

Ans: The Types covered in the Opiate Antagonist Market report are 0.4 mg/ml, 1 mg/ml, 2 mg/ml

Recommended Reports

Opioid and Pain Relief

Sleep and Insomnia

Diagnostics and Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Opiate Antagonist Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 0.4 mg/ml

1.2.3 1 mg/ml

1.2.4 2 mg/ml

1.3 Market by Application

1.3.1 Global Opiate Antagonist Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Pharmacy

1.3.5 Home

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Opiate Antagonist Market Perspective (2019-2030)

2.2 Opiate Antagonist Growth Trends by Region

2.2.1 Global Opiate Antagonist Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Opiate Antagonist Historic Market Size by Region (2019-2024)

2.2.3 Opiate Antagonist Forecasted Market Size by Region (2025-2030)

2.3 Opiate Antagonist Market Dynamics

2.3.1 Opiate Antagonist Industry Trends

2.3.2 Opiate Antagonist Market Drivers

2.3.3 Opiate Antagonist Market Challenges

2.3.4 Opiate Antagonist Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Opiate Antagonist Players by Revenue

3.1.1 Global Top Opiate Antagonist Players by Revenue (2019-2024)

3.1.2 Global Opiate Antagonist Revenue Market Share by Players (2019-2024)

3.2 Global Opiate Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Opiate Antagonist Revenue

3.4 Global Opiate Antagonist Market Concentration Ratio

3.4.1 Global Opiate Antagonist Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Opiate Antagonist Revenue in 2023

3.5 Opiate Antagonist Key Players Head office and Area Served

3.6 Key Players Opiate Antagonist Product Solution and Service

3.7 Date of Enter into Opiate Antagonist Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Opiate Antagonist Breakdown Data by Type

4.1 Global Opiate Antagonist Historic Market Size by Type (2019-2024)

4.2 Global Opiate Antagonist Forecasted Market Size by Type (2025-2030)

5 Opiate Antagonist Breakdown Data by Application

5.1 Global Opiate Antagonist Historic Market Size by Application (2019-2024)

5.2 Global Opiate Antagonist Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Opiate Antagonist Market Size (2019-2030)

6.2 North America Opiate Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Opiate Antagonist Market Size by Country (2019-2024)

6.4 North America Opiate Antagonist Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Opiate Antagonist Market Size (2019-2030)

7.2 Europe Opiate Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Opiate Antagonist Market Size by Country (2019-2024)

7.4 Europe Opiate Antagonist Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Opiate Antagonist Market Size (2019-2030)

8.2 Asia-Pacific Opiate Antagonist Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Opiate Antagonist Market Size by Region (2019-2024)

8.4 Asia-Pacific Opiate Antagonist Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Opiate Antagonist Market Size (2019-2030)

9.2 Latin America Opiate Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Opiate Antagonist Market Size by Country (2019-2024)

9.4 Latin America Opiate Antagonist Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Opiate Antagonist Market Size (2019-2030)

10.2 Middle East & Africa Opiate Antagonist Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Opiate Antagonist Market Size by Country (2019-2024)

10.4 Middle East & Africa Opiate Antagonist Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Opiate Antagonist Introduction

11.1.4 Pfizer Revenue in Opiate Antagonist Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Sun Pharmaceutical Industries

11.2.1 Sun Pharmaceutical Industries Company Detail

11.2.2 Sun Pharmaceutical Industries Business Overview

11.2.3 Sun Pharmaceutical Industries Opiate Antagonist Introduction

11.2.4 Sun Pharmaceutical Industries Revenue in Opiate Antagonist Business (2019-2024)

11.2.5 Sun Pharmaceutical Industries Recent Development

11.3 Teva Pharmaceuticals

11.3.1 Teva Pharmaceuticals Company Detail

11.3.2 Teva Pharmaceuticals Business Overview

11.3.3 Teva Pharmaceuticals Opiate Antagonist Introduction

11.3.4 Teva Pharmaceuticals Revenue in Opiate Antagonist Business (2019-2024)

11.3.5 Teva Pharmaceuticals Recent Development

11.4 Cardinal Health

11.4.1 Cardinal Health Company Detail

11.4.2 Cardinal Health Business Overview

11.4.3 Cardinal Health Opiate Antagonist Introduction

11.4.4 Cardinal Health Revenue in Opiate Antagonist Business (2019-2024)

11.4.5 Cardinal Health Recent Development

11.5 Baxter Pharmaceutical

11.5.1 Baxter Pharmaceutical Company Detail

11.5.2 Baxter Pharmaceutical Business Overview

11.5.3 Baxter Pharmaceutical Opiate Antagonist Introduction

11.5.4 Baxter Pharmaceutical Revenue in Opiate Antagonist Business (2019-2024)

11.5.5 Baxter Pharmaceutical Recent Development

11.6 Adapt Pharmaceuticals

11.6.1 Adapt Pharmaceuticals Company Detail

11.6.2 Adapt Pharmaceuticals Business Overview

11.6.3 Adapt Pharmaceuticals Opiate Antagonist Introduction

11.6.4 Adapt Pharmaceuticals Revenue in Opiate Antagonist Business (2019-2024)

11.6.5 Adapt Pharmaceuticals Recent Development

11.7 Dr. Reddy's Laboratories

11.7.1 Dr. Reddy's Laboratories Company Detail

11.7.2 Dr. Reddy's Laboratories Business Overview

11.7.3 Dr. Reddy's Laboratories Opiate Antagonist Introduction

11.7.4 Dr. Reddy's Laboratories Revenue in Opiate Antagonist Business (2019-2024)

11.7.5 Dr. Reddy's Laboratories Recent Development

11.8 GIV Repack

11.8.1 GIV Repack Company Detail

11.8.2 GIV Repack Business Overview

11.8.3 GIV Repack Opiate Antagonist Introduction

11.8.4 GIV Repack Revenue in Opiate Antagonist Business (2019-2024)

11.8.5 GIV Repack Recent Development

11.9 Intl Medication Systems

11.9.1 Intl Medication Systems Company Detail

11.9.2 Intl Medication Systems Business Overview

11.9.3 Intl Medication Systems Opiate Antagonist Introduction

11.9.4 Intl Medication Systems Revenue in Opiate Antagonist Business (2019-2024)

11.9.5 Intl Medication Systems Recent Development

11.10 Kaleo Pharma

11.10.1 Kaleo Pharma Company Detail

11.10.2 Kaleo Pharma Business Overview

11.10.3 Kaleo Pharma Opiate Antagonist Introduction

11.10.4 Kaleo Pharma Revenue in Opiate Antagonist Business (2019-2024)

11.10.5 Kaleo Pharma Recent Development

11.11 Mylan Institutional

11.11.1 Mylan Institutional Company Detail

11.11.2 Mylan Institutional Business Overview

11.11.3 Mylan Institutional Opiate Antagonist Introduction

11.11.4 Mylan Institutional Revenue in Opiate Antagonist Business (2019-2024)

11.11.5 Mylan Institutional Recent Development

11.12 Perrigo Pharmaceuticals

11.12.1 Perrigo Pharmaceuticals Company Detail

11.12.2 Perrigo Pharmaceuticals Business Overview

11.12.3 Perrigo Pharmaceuticals Opiate Antagonist Introduction

11.12.4 Perrigo Pharmaceuticals Revenue in Opiate Antagonist Business (2019-2024)

11.12.5 Perrigo Pharmaceuticals Recent Development

11.13 AuroMedics Pharma

11.13.1 AuroMedics Pharma Company Detail

11.13.2 AuroMedics Pharma Business Overview

11.13.3 AuroMedics Pharma Opiate Antagonist Introduction

11.13.4 AuroMedics Pharma Revenue in Opiate Antagonist Business (2019-2024)

11.13.5 AuroMedics Pharma Recent Development

11.14 Somerset Pharma

11.14.1 Somerset Pharma Company Detail

11.14.2 Somerset Pharma Business Overview

11.14.3 Somerset Pharma Opiate Antagonist Introduction

11.14.4 Somerset Pharma Revenue in Opiate Antagonist Business (2019-2024)

11.14.5 Somerset Pharma Recent Development

11.15 Akorn

11.15.1 Akorn Company Detail

11.15.2 Akorn Business Overview

11.15.3 Akorn Opiate Antagonist Introduction

11.15.4 Akorn Revenue in Opiate Antagonist Business (2019-2024)

11.15.5 Akorn Recent Development

11.16 Alkermes

11.16.1 Alkermes Company Detail

11.16.2 Alkermes Business Overview

11.16.3 Alkermes Opiate Antagonist Introduction

11.16.4 Alkermes Revenue in Opiate Antagonist Business (2019-2024)

11.16.5 Alkermes Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Pfizer Inc

Sun Pharmaceutical Industries

Teva Pharmaceuticals

Cardinal Health

Dr. Reddy’s Laboratories

Mylan Institutional

Perrigo Pharmaceuticals

AuroMedics Pharma

Akorn

Alkermes plc

Baxter Pharmaceutical

Adapt Pharmaceuticals

GIV Repack

Intl Medication Systems

Kaleo Pharma

Somerset Pharma

List of Tables

Table 1. Global Opiate Antagonist Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of 0.4 mg/ml

Table 3. Key Players of 1 mg/ml

Table 4. Key Players of 2 mg/ml

Table 5. Global Opiate Antagonist Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Opiate Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Opiate Antagonist Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Opiate Antagonist Market Share by Region (2019-2024)

Table 9. Global Opiate Antagonist Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Opiate Antagonist Market Share by Region (2025-2030)

Table 11. Opiate Antagonist Market Trends

Table 12. Opiate Antagonist Market Drivers

Table 13. Opiate Antagonist Market Challenges

Table 14. Opiate Antagonist Market Restraints

Table 15. Global Opiate Antagonist Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Opiate Antagonist Market Share by Players (2019-2024)

Table 17. Global Top Opiate Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opiate Antagonist as of 2023)

Table 18. Ranking of Global Top Opiate Antagonist Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Opiate Antagonist Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Opiate Antagonist Product Solution and Service

Table 22. Date of Enter into Opiate Antagonist Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Opiate Antagonist Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Opiate Antagonist Revenue Market Share by Type (2019-2024)

Table 26. Global Opiate Antagonist Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Opiate Antagonist Revenue Market Share by Type (2025-2030)

Table 28. Global Opiate Antagonist Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Opiate Antagonist Revenue Market Share by Application (2019-2024)

Table 30. Global Opiate Antagonist Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Opiate Antagonist Revenue Market Share by Application (2025-2030)

Table 32. North America Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Opiate Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Opiate Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Opiate Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Opiate Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Opiate Antagonist Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Opiate Antagonist Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Opiate Antagonist Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Opiate Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Opiate Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Opiate Antagonist Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Opiate Antagonist Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Opiate Antagonist Market Size by Country (2025-2030) & (US$ Million)

Table 47. Pfizer Company Detail

Table 48. Pfizer Business Overview

Table 49. Pfizer Opiate Antagonist Product

Table 50. Pfizer Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Sun Pharmaceutical Industries Company Detail

Table 53. Sun Pharmaceutical Industries Business Overview

Table 54. Sun Pharmaceutical Industries Opiate Antagonist Product

Table 55. Sun Pharmaceutical Industries Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 56. Sun Pharmaceutical Industries Recent Development

Table 57. Teva Pharmaceuticals Company Detail

Table 58. Teva Pharmaceuticals Business Overview

Table 59. Teva Pharmaceuticals Opiate Antagonist Product

Table 60. Teva Pharmaceuticals Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 61. Teva Pharmaceuticals Recent Development

Table 62. Cardinal Health Company Detail

Table 63. Cardinal Health Business Overview

Table 64. Cardinal Health Opiate Antagonist Product

Table 65. Cardinal Health Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 66. Cardinal Health Recent Development

Table 67. Baxter Pharmaceutical Company Detail

Table 68. Baxter Pharmaceutical Business Overview

Table 69. Baxter Pharmaceutical Opiate Antagonist Product

Table 70. Baxter Pharmaceutical Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 71. Baxter Pharmaceutical Recent Development

Table 72. Adapt Pharmaceuticals Company Detail

Table 73. Adapt Pharmaceuticals Business Overview

Table 74. Adapt Pharmaceuticals Opiate Antagonist Product

Table 75. Adapt Pharmaceuticals Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 76. Adapt Pharmaceuticals Recent Development

Table 77. Dr. Reddy's Laboratories Company Detail

Table 78. Dr. Reddy's Laboratories Business Overview

Table 79. Dr. Reddy's Laboratories Opiate Antagonist Product

Table 80. Dr. Reddy's Laboratories Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 81. Dr. Reddy's Laboratories Recent Development

Table 82. GIV Repack Company Detail

Table 83. GIV Repack Business Overview

Table 84. GIV Repack Opiate Antagonist Product

Table 85. GIV Repack Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 86. GIV Repack Recent Development

Table 87. Intl Medication Systems Company Detail

Table 88. Intl Medication Systems Business Overview

Table 89. Intl Medication Systems Opiate Antagonist Product

Table 90. Intl Medication Systems Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 91. Intl Medication Systems Recent Development

Table 92. Kaleo Pharma Company Detail

Table 93. Kaleo Pharma Business Overview

Table 94. Kaleo Pharma Opiate Antagonist Product

Table 95. Kaleo Pharma Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 96. Kaleo Pharma Recent Development

Table 97. Mylan Institutional Company Detail

Table 98. Mylan Institutional Business Overview

Table 99. Mylan Institutional Opiate Antagonist Product

Table 100. Mylan Institutional Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 101. Mylan Institutional Recent Development

Table 102. Perrigo Pharmaceuticals Company Detail

Table 103. Perrigo Pharmaceuticals Business Overview

Table 104. Perrigo Pharmaceuticals Opiate Antagonist Product

Table 105. Perrigo Pharmaceuticals Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 106. Perrigo Pharmaceuticals Recent Development

Table 107. AuroMedics Pharma Company Detail

Table 108. AuroMedics Pharma Business Overview

Table 109. AuroMedics Pharma Opiate Antagonist Product

Table 110. AuroMedics Pharma Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 111. AuroMedics Pharma Recent Development

Table 112. Somerset Pharma Company Detail

Table 113. Somerset Pharma Business Overview

Table 114. Somerset Pharma Opiate Antagonist Product

Table 115. Somerset Pharma Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 116. Somerset Pharma Recent Development

Table 117. Akorn Company Detail

Table 118. Akorn Business Overview

Table 119. Akorn Opiate Antagonist Product

Table 120. Akorn Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 121. Akorn Recent Development

Table 122. Alkermes Company Detail

Table 123. Alkermes Business Overview

Table 124. Alkermes Opiate Antagonist Product

Table 125. Alkermes Revenue in Opiate Antagonist Business (2019-2024) & (US$ Million)

Table 126. Alkermes Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Opiate Antagonist Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Opiate Antagonist Market Share by Type: 2023 VS 2030

Figure 3. 0.4 mg/ml Features

Figure 4. 1 mg/ml Features

Figure 5. 2 mg/ml Features

Figure 6. Global Opiate Antagonist Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Opiate Antagonist Market Share by Application: 2023 VS 2030

Figure 8. Hospital Case Studies

Figure 9. Clinics Case Studies

Figure 10. Pharmacy Case Studies

Figure 11. Home Case Studies

Figure 12. Others Case Studies

Figure 13. Opiate Antagonist Report Years Considered

Figure 14. Global Opiate Antagonist Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Opiate Antagonist Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Opiate Antagonist Market Share by Region: 2023 VS 2030

Figure 17. Global Opiate Antagonist Market Share by Players in 2023

Figure 18. Global Top Opiate Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opiate Antagonist as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Opiate Antagonist Revenue in 2023

Figure 20. North America Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Opiate Antagonist Market Share by Country (2019-2030)

Figure 22. United States Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Opiate Antagonist Market Share by Country (2019-2030)

Figure 26. Germany Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Opiate Antagonist Market Share by Region (2019-2030)

Figure 34. China Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Opiate Antagonist Market Share by Country (2019-2030)

Figure 42. Mexico Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Opiate Antagonist Market Share by Country (2019-2030)

Figure 46. Turkey Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Opiate Antagonist Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 49. Sun Pharmaceutical Industries Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 50. Teva Pharmaceuticals Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 51. Cardinal Health Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 52. Baxter Pharmaceutical Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 53. Adapt Pharmaceuticals Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 54. Dr. Reddy's Laboratories Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 55. GIV Repack Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 56. Intl Medication Systems Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 57. Kaleo Pharma Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 58. Mylan Institutional Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 59. Perrigo Pharmaceuticals Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 60. AuroMedics Pharma Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 61. Somerset Pharma Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 62. Akorn Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 63. Alkermes Revenue Growth Rate in Opiate Antagonist Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Dopamine Antagonist Market Research Report 2024

Global Opioid Withdrawal Syndrome Market Research Report 2024

Global Glutamate Antagonist Market Research Report 2025

Vasopressin Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Loxonin Market Research Report 2025

Global CGRP Receptor Antagonists Market Research Report 2024

Global Opioid Analgesics Market Research Report 2025

Global Opioid Use Disorder Treatment Market Research Report 2024

Global Potassium Competitive Antagonist Market Research Report 2024

Global Oxidation Inhibitors Market Research Report 2024

Global NMDA Receptor Antagonist Market Research Report 2025

Global Dopamine Receptor Antagonist Market Research Report 2024

Global Nociceptin Receptor Market Research Report 2024

Global Brimonidine Market Research Report 2024

Global Narcotics Analyzer Market Research Report 2025

Narcotic Opioid Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Famotidine Drugs Market Research Report 2025

Opioid Withdrawal Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Famotidine for Injection Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions